...
首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Development and validation of a selective and sensitive bioanalytical procedure for the quantitative determination of gaboxadol in human plasma employing mixed mode solid phase extraction and hydrophilic interaction liquid chromatography with tandem
【24h】

Development and validation of a selective and sensitive bioanalytical procedure for the quantitative determination of gaboxadol in human plasma employing mixed mode solid phase extraction and hydrophilic interaction liquid chromatography with tandem

机译:混合模式固相萃取和串联亲水相互作用色谱法开发和验证用于定量测定人血浆中加波沙朵的选择性和灵敏生物分析程序

获取原文
获取原文并翻译 | 示例
           

摘要

A selective and sensitive hydrophilic interaction liquid chromatography tandem mass spectrometric bioanalytical method for the quantitative determination of gaboxadol in human heparinized plasma was developed and validated. Gaboxadol and the stable isotope labeled internal standard were extracted from plasma by mixed mode solid phase extraction and analyzed on an Asahipak NH2P HPLC column with a mobile phase composed of 70% acetonitrile and 30% ammonium acetate (20 mM, pH 4). The analytes were detected by a SCIEX API 4000 triple quadropole instrument using turbo electrospray ionization and multiple reaction monitoring negative mode. The method was validated over the concentration range of 0.5-100 ng/mL. The intra-day precision of the assay, as measured by the coefficient of variation (CV%), was within 4%. The intra-day assay accuracy was found to be within 2.2% of the nominal concentration for all the standards. The average recovery of gaboxadol was about 87% and the ion suppression was approximately 8%. To eliminate late eluters including the glucuronides, a "front cut" column switching procedure was added to the chromatographic system. The effectiveness of the column switching in eliminating the absolute matrix effect caused by late eluters was demonstrated by the low variation (CV < 3.5%) in the peak areas of the internal standard during the assessment of the inter-day precision and accuracy and no significant relative matrix effect was observed as illustrated by the excellent intra-day precision (CV < 1.5%) from the assessment of standard samples prepared in five different lots of control plasma. The described bioanalytical method has been successfully utilized for the analysis of gaboxadol in post-dose samples (>8000) from various clinical studies. Inter-day precision and accuracy were assessed from the daily mean (n = 2) of QC values from 52 runs, i.e. more than 3000 samples. The inter-day precision of the assay, based on the coefficient of variation of QC. ranged from 2.1 to 5.1%. The inter-day assay accuracy was found to be within 4% of the nominal concentration for all QC samples. (C) 2007 Elsevier B.V. All rights reserved.
机译:建立并验证了一种选择性灵敏的亲水相互作用液相色谱串联质谱生物分析方法定量测定人肝素化血浆中加波沙朵的方法。通过混合模式固相萃取从血浆中萃取出加波沙朵和稳定同位素标记的内标,并在Asahipak NH2P HPLC色谱柱上进行分析,流动相由70%乙腈和30%醋酸铵(20 mM,pH 4)组成。通过SCIEX API 4000三重四极杆仪器使用涡轮电喷雾电离和多反应监测负离子模式检测分析物。该方法在0.5-100 ng / mL的浓度范围内得到验证。通过变异系数(CV%)测量的日内测定精度在4%以内。发现所有标准品的日内测定准确性均在名义浓度的2.2%以内。加波沙朵的平均回收率约为87%,离子抑制约为8%。为了消除包括葡萄糖醛酸苷在内的晚期洗脱物,将“前切”色谱柱切换程序添加到了色谱系统中。在评估日间精密度和准确度时,内标峰面积的变异小(CV <3.5%),证明了柱切换在消除晚期洗脱剂引起的绝对基质效应方面的有效性。通过评估五种不同对照血浆中制备的标准样品获得的出色的日内精度(CV <1.5%),可以观察到相对基质效应。所描述的生物分析方法已成功用于各种临床研究的剂量后样品(> 8000)中加波沙朵的分析。根据52次运行(即3000多个样本)的QC值的每日平均值(n = 2)评估日间精度和准确性。基于QC的变异系数,测定的日间精度。范围从2.1%到5.1%。发现所有QC样品的日间测定准确度在名义浓度的4%以内。 (C)2007 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号